Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Oncology: Clinical Therapy and Diagnosis

  • You have access
    N-Staging of men with prostate carcinoma - correlation of PSMA-PET/CT imaging and Roach Formula in 280 treatment-naïve patients
    Frederik Giesel, Clemens Kratochwil, Gerald Stach, Hendrik Rathke, Klaus Kopka, Tim Holland-Letz, Uwe Haberkorn, Juergen Debus and Stefan Koerber
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1583;
  • You have access
    Comparison of FDG PET/CT and CT in response assessment and prognosis of patients with extra medullary disease in acute myeloid leukemia
    Rakesh Kumar, Nalli Harish, Anshul Sharma, Ravi Kant Gupta, Akshima Sharma, Sameer Bakhshi, Chetan Patel, Arunraj Sreedharan Thankarajan and Chandrasekhar Bal
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1251;
  • You have access
    A long-term outcome study on 177Lu-PSMA-617 Radioligand Therapy in metastatic castration Resistant Prostate Cancer: Single-institutional Results
    Madhav Yadav, Sanjana Ballal, Ranjit Sahoo, Madhavi Tripathi and Nishikant Damle
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 463;
  • You have access
    An effectiveness of apitherapy in acute salivary gland disorder following radioactive iodine therapy for differentiated thyroid cancer
    Michihiro Nakayama and Atsutaka Okizaki
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1544;
  • You have access
    KRAS missense mutation effects on the 18F-FDG uptake of colorectal adenocarcinoma metastases in the liver
    Assen Kirov, Marko Popovic, Snjezana Dogan, Daniel Lafontaine, Christian Czmielewski, Marius Mayerhoefer, John Humm, Heiko Schoder and Stephen Solomon
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 213;
  • You have access
    Role of dual tracer 68Ga-DOTATOC and 18F-FDG PET/CT in preoperative risk assessment in pancreatic neuroendocrine neoplasms
    Paola Mapelli, Matteo Salgarello, Stefano Partelli, Francesca Muffatti, Joniada Doraku, Stefano Pasetto, Paola Maria Rancoita, Valentina Andreasi, Luigi Gianolli, Massimo Falconi and Maria Picchio
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 475;
  • You have access
    Lung nodule characterization: can the combination of CT and FDG PET parameters improve ability to predict malignancy?
    Marisa Rivera, Minh Nguyen, Diane Carpenter, Debbie Postlethwaite, Joseph Vu and Ryan Niederkohr
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1328;
  • You have access
    Differential Diagnostic value of Intensity- and Volume-based Parameters of 18F-FDG PET/CT in Primary Cardiac Tumors with Increased 18F-FDG uptake
    En-Tao Liu, Taotao Sun, Dan Shao, Haojian Dong, Zerui Chen, Chao Liu, Xiaochun Zhang, Zhouyang Lian, Siyun Wang and Shuxia Wang
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 1274;
  • You have access
    Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY
    Steven Rowe, Michael Gorin, Kenneth Pienta, Barry Siegel, Peter Carroll, Frederic Pouliot, Stephan Probst, Lawrence Saperstein, Mark Preston, Ajjai Alva, Akash Patnaik, Jeremy Durack, Melissa Nichols, Tess Lin, Jessica Jensen, Vivien Wong and Michael Morris
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 586;
  • You have access
    Intensity of tracer-uptake in FAPI-PET/CT in different kinds of cancer
    Frederik Giesel, Paul Flechsig, Abderrahim Labidi, Hendrik Rathke, Manuel Röhrich, Juergen Debus, Dirk Jaeger, Altmann Anette, Anastasia Loktev, Thomas Lindner, Uwe Haberkorn and Clemens Kratochwil
    Journal of Nuclear Medicine May 1, 2019, 60 (supplement 1) 289;

Pages

  • Previous
  • Next
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire